Squamous cell carcinoma of lung
|
0.300 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Red Blood Cell Count measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Red cell distribution width determination
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
RDW - Red blood cell distribution width result
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
mathematical ability
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals.
|
30038396 |
2018 |
Finding of Mean Corpuscular Hemoglobin
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases.
|
29403010 |
2018 |
Overweight and obesity
|
0.020 |
Biomarker
|
disease |
BEFREE |
One hundred thirty physically inactive women and men (20-45 yr) with overweight and obesity were randomized to 6 mo of habitual lifestyle (CON, n = 18), active commuting (BIKE, n = 35), or leisure-time exercise of moderate [MOD, 50% peak oxygen uptake (V̇o<sub>2peak</sub>)-reserve, n = 39] or vigorous (VIG, 70% V̇o<sub>2peak</sub>-reserve, n = 38) intensity.
|
30605397 |
2019 |
Overweight and obesity
|
0.020 |
Biomarker
|
disease |
BEFREE |
We randomized 130 younger, physically inactive women and men with overweight and obesity (body mass index: 25-35 kg m<sup>-</sup><sup>2</sup>) to 6 months of habitual lifestyle (control; CON, n=18), active commuting (BIKE, n=35) or leisure-time exercise of moderate (MOD, 50% VO<sub>2</sub>peak reserve, n=39) or vigorous intensity (VIG, 70% VO<sub>2</sub>peak reserve, n=38).
|
28993707 |
2018 |
Tumor Cell Invasion
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Bone morphogenetic protein 2-inducible kinase (BMP2K) binds to the INV region and contributes to IRS2-dependent invasion.
|
29685905 |
2018 |
Obesity
|
0.010 |
Biomarker
|
disease |
BEFREE |
We randomized 130 younger (20-45 years), physically inactive, healthy, overweight and obese (BMI: 25-35 kg/m<sup>2</sup>) women and men recruited from the Copenhagen area, Denmark, to either 6 months of habitual lifestyle (CON, n = 18), active commuting (BIKE, n = 35), or leisure time exercise of moderate (MOD, ∼50% VO<sub>2</sub>peak, n = 39) or vigorous intensity (VIG, ∼70% VO<sub>2</sub>peak, n = 38).
|
28679486 |
2017 |
Congenital Dysplasia Of The Hip
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Two novel heterozygous, inframe mutations causing multi-nucleotide substitution polymorphisms (c.1432_1440delCAGCAGCAG corresponding with p.Gln478_480del and c.1440_1441insCAG corresponding with p.Gln480ins) in exon 11 of chromosome 4 in bone morphogenetic proteins-2-inducible kinase (BMP2K) were identified; these were found in members of the pedigree affected by DDH and in the unaffected grandmother of the proband, who was deemed to be the carrier of potential mutations, but not in the unaffected normal control saunt of the proband.
|
28565766 |
2017 |
Chronic Lymphocytic Leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
BMP2K, a gene not previously linked to CLL, was also identified as a modulator of response to fludarabine.
|
26957556 |
2016 |
Myopia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
These data suggest that BMP2K gene 1379 G/A variant is strongly correlated with high myopia and may contribute to a genetic risk factor for high degrees of myopic pathogenesis.
|
19927351 |
2009 |
Severe myopia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
These data suggest that BMP2K gene 1379 G/A variant is strongly correlated with high myopia and may contribute to a genetic risk factor for high degrees of myopic pathogenesis.
|
19927351 |
2009 |
Osteoporosis
|
0.010 |
GeneticVariation
|
disease |
LHGDN |
BMP-2 gene polymorphisms and osteoporosis: the Rotterdam Study.
|
16753015 |
2006 |